PR Newswire BiotechOriginal article
Terapia de edición bases con tBE logra remisión clínica duradera en drepanocitosis y β-talasemia en varios fondos genét
Data ReadoutpositivetBEPositive
AI Analysis
Summary
Base editing therapy (tBE) achieved durable clinical remission in sickle cell disease and β-thalassemia patients across different genetic backgrounds, with transfusion independence demonstrated in Chinese thalassemia patients, as published in Cell Stem Cell.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
Base editing therapy achieved durable clinical remission in sickle cell disease and β-thalassemia across different genetic contexts; achieved transfusion independence in Chinese thalassemia patients
Importance:7/10
Sentiment:
0.80
gene_editingbase_editingsickle_cell_diseasebeta_thalassemiaclinical_remissiontransfusion_independence
Read the original article
Published by PR Newswire Biotech on September 9, 2026 9:00 AM